TOVX

$0.00

(

+0.00%

)
Quote details

stock

Theriva Biologics Inc.

NYSE MKT | TOVX

0.39

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 26, 2025)

$3.74M

Market Cap

-

P/E Ratio

-4.22

EPS

$2.64

52 Week High

$0.36

52 Week Low

HEALTHCARE

Sector

TOVX Chart

Recent Chart
Price Action

TOVX Technicals

Tags:

TOVX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$137K
Total Revenue $0
Cost Of Revenue $137K
Costof Goods And Services Sold $137K
Operating Income -$19M
Selling General And Administrative $7.4M
Research And Development $12M
Operating Expenses $19M
Investment Income Net -
Net Interest Income $697K
Interest Income $697K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $137K
Income Before Tax -$26M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$26M
Comprehensive Income Net Of Tax -
Ebit -$26M
Ebitda -$26M
Net Income -$26M

Revenue & Profitability

Earnings Performance

TOVX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $35M
Total Current Assets $16M
Cash And Cash Equivalents At Carrying Value $12M
Cash And Short Term Investments $12M
Inventory -
Current Net Receivables $3.3M
Total Non Current Assets $19M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $17M
Intangible Assets Excluding Goodwill $17M
Goodwill $0
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.3M
Other Non Current Assets -
Total Liabilities $16M
Total Current Liabilities $7.6M
Current Accounts Payable $859K
Deferred Revenue -
Current Debt -
Short Term Debt $600K
Total Non Current Liabilities $8.7M
Capital Lease Obligations $1.4M
Long Term Debt $92K
Current Long Term Debt $61K
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.6M
Other Current Liabilities $6.1M
Other Non Current Liabilities $7M
Total Shareholder Equity $19M
Treasury Stock -
Retained Earnings -$335M
Common Stock $3K
Common Stock Shares Outstanding $1.3M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$17M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $137K
Capital Expenditures $1K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$1K
Cashflow From Financing $5.5M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$26M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$137K
Total Revenue $0
Cost Of Revenue $137K
Costof Goods And Services Sold $137K
Operating Income -$19M
Selling General And Administrative $7.4M
Research And Development $12M
Operating Expenses $19M
Investment Income Net -
Net Interest Income $697K
Interest Income $697K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $137K
Income Before Tax -$26M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$26M
Comprehensive Income Net Of Tax -
Ebit -$26M
Ebitda -$26M
Net Income -$26M

TOVX Profile

Theriva Biologics Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Theriva Biologics Inc. (TOVX) is a clinical-stage biotechnology firm based in Rockville, Maryland, focused on developing innovative therapies for diseases with significant unmet medical needs. The company leverages its proprietary technologies to create targeted biologics aimed at improving patient outcomes. With a robust pipeline and a dedicated team of experts, Theriva is positioned to make substantial contributions to therapeutic areas that require novel treatment options.

DVLT
+30.57%
$1.09
INTC
+4.44%
$35.50
GPUS
+19.56%
$0.45
CGBS
-39.47%
$0.03
DFLI
+38.45%
$0.52
NEHC
+33.33%
$1.84
NUAI
+33.33%
$1.84
SNAP
-0.72%
$8.27
CJET
+10.63%
$0.17
NVDA
+0.28%
$178.19
F
+3.35%
$12.01
DNN
-3.14%
$2.77
PSTV
+9.60%
$0.61
APLT
+121.34%
$1.24
TSLA
+4.01%
$440.40
RGTI
-2.86%
$31.18
BIAF
+55.13%
$5.29
YAAS
-8.19%
$0.09
PLUG
+0.42%
$2.37
CIFR
-1.62%
$11.47
NIO
-5.75%
$7.04
ADAP
+15.74%
$0.14
AAL
-0.70%
$11.31
WOK
-5.22%
$0.08
RIG
+0.94%
$3.19
IONZ
+5.83%
$4.34
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
MRM
+102.75%
$2.94
QBTS
+1.59%
$26.76
VALE
-1.74%
$10.70
IREN
-9.57%
$41.86
BLMZ
+12.51%
$0.20
BTG
+1.44%
$4.92
QUBT
-2.11%
$20.14
MARA
+0.37%
$16.13
KVUE
+1.54%
$16.42
RIOT
+5.67%
$17.69
KDLY
+7.69%
$1.26
RXRX
-5.12%
$4.63
AAPL
-0.54%
$255.46
ATCH
-4.22%
$0.79
PLTR
-0.86%
$177.57
SOUN
-2.50%
$15.94
BBD
+0.91%
$3.30
BITF
-5.22%
$2.54
TLRY
-3.36%
$1.14
WBD
-1.36%
$19.51
AMZN
+0.74%
$219.78
FCX
+1.14%
$35.74
BURU
-10.14%
$0.12
IXHL
-0.01%
$0.59
BMNR
+1.69%
$50.41
RMBL
+60.50%
$3.21
ETHD
-5.95%
$3.95
SHOT
+12.24%
$0.28
GRAB
-2.24%
$6.11
ADD
-25.47%
$0.05
CLSK
-5.32%
$13.68
RAYA
-3.15%
$0.04
RR
+2.68%
$4.20
RIVN
-0.95%
$15.59
ONDS
-1.16%
$7.66
SOFI
-0.49%
$27.98
BULL
+3.55%
$15.16
CVE
+0.39%
$17.77
SRM
+53.27%
$10.30
PFE
+0.67%
$23.76
ACHR
-0.53%
$9.27
IONQ
-3.09%
$67.28
BB
+6.34%
$4.94
JOBY
+1.63%
$16.12
NOK
-0.42%
$4.66
AMD
-1.12%
$159.46
CRWV
-4.98%
$120.34
CLF
+2.48%
$12.37
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BTE
+2.64%
$2.52
QS
+1.28%
$12.66
WLGS
-5.57%
$0.04
HIMS
+6.39%
$58.38
ABEV
0.00%
$2.29
AQMS
+48.37%
$7.30
MRVL
-0.76%
$83.17
ETWO
0.00%
$3.30
ORCL
-2.70%
$283.45
HBAN
+0.57%
$17.42
AG
+4.02%
$12.14
HOOD
-0.70%
$121.78
NWTN
-15.63%
$2.04
AIIO
-15.63%
$2.04
SDM
-86.40%
$1.85
T
+0.03%
$28.31
OKLO
-7.21%
$110.53
ITUB
+0.55%
$7.24
MU
+0.28%
$157.27
PCG
+3.67%
$14.97
AFMD
-34.94%
$0.18
WULF
-1.27%
$10.83
DVLT
+30.57%
$1.09
INTC
+4.44%
$35.50
GPUS
+19.56%
$0.45
CGBS
-39.47%
$0.03
DFLI
+38.45%
$0.52
NEHC
+33.33%
$1.84
NUAI
+33.33%
$1.84
SNAP
-0.72%
$8.27
CJET
+10.63%
$0.17
NVDA
+0.28%
$178.19
F
+3.35%
$12.01
DNN
-3.14%
$2.77
PSTV
+9.60%
$0.61
APLT
+121.34%
$1.24
TSLA
+4.01%
$440.40
RGTI
-2.86%
$31.18
BIAF
+55.13%
$5.29
YAAS
-8.19%
$0.09
PLUG
+0.42%
$2.37
CIFR
-1.62%
$11.47
NIO
-5.75%
$7.04
ADAP
+15.74%
$0.14
AAL
-0.70%
$11.31
WOK
-5.22%
$0.08
RIG
+0.94%
$3.19
IONZ
+5.83%
$4.34
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
MRM
+102.75%
$2.94
QBTS
+1.59%
$26.76
VALE
-1.74%
$10.70
IREN
-9.57%
$41.86
BLMZ
+12.51%
$0.20
BTG
+1.44%
$4.92
QUBT
-2.11%
$20.14
MARA
+0.37%
$16.13
KVUE
+1.54%
$16.42
RIOT
+5.67%
$17.69
KDLY
+7.69%
$1.26
RXRX
-5.12%
$4.63
AAPL
-0.54%
$255.46
ATCH
-4.22%
$0.79
PLTR
-0.86%
$177.57
SOUN
-2.50%
$15.94
BBD
+0.91%
$3.30
BITF
-5.22%
$2.54
TLRY
-3.36%
$1.14
WBD
-1.36%
$19.51
AMZN
+0.74%
$219.78
FCX
+1.14%
$35.74
BURU
-10.14%
$0.12
IXHL
-0.01%
$0.59
BMNR
+1.69%
$50.41
RMBL
+60.50%
$3.21
ETHD
-5.95%
$3.95
SHOT
+12.24%
$0.28
GRAB
-2.24%
$6.11
ADD
-25.47%
$0.05
CLSK
-5.32%
$13.68
RAYA
-3.15%
$0.04
RR
+2.68%
$4.20
RIVN
-0.95%
$15.59
ONDS
-1.16%
$7.66
SOFI
-0.49%
$27.98
BULL
+3.55%
$15.16
CVE
+0.39%
$17.77
SRM
+53.27%
$10.30
PFE
+0.67%
$23.76
ACHR
-0.53%
$9.27
IONQ
-3.09%
$67.28
BB
+6.34%
$4.94
JOBY
+1.63%
$16.12
NOK
-0.42%
$4.66
AMD
-1.12%
$159.46
CRWV
-4.98%
$120.34
CLF
+2.48%
$12.37
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BTE
+2.64%
$2.52
QS
+1.28%
$12.66
WLGS
-5.57%
$0.04
HIMS
+6.39%
$58.38
ABEV
0.00%
$2.29
AQMS
+48.37%
$7.30
MRVL
-0.76%
$83.17
ETWO
0.00%
$3.30
ORCL
-2.70%
$283.45
HBAN
+0.57%
$17.42
AG
+4.02%
$12.14
HOOD
-0.70%
$121.78
NWTN
-15.63%
$2.04
AIIO
-15.63%
$2.04
SDM
-86.40%
$1.85
T
+0.03%
$28.31
OKLO
-7.21%
$110.53
ITUB
+0.55%
$7.24
MU
+0.28%
$157.27
PCG
+3.67%
$14.97
AFMD
-34.94%
$0.18
WULF
-1.27%
$10.83

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.